Robust Vial Integrity: Our vials feature thick borosilicate glass, durable rubber stoppers, and tamper-evident flip caps to lock out oxygen and humidity
On February 20, 2023, the National Medical Products Administration of China has approved Upatinib sustained-release tablets (trade name: Refo) for the cure of suffers with moderate to severe active UC who do not respond well to or are intolerant or contraindication to one or more tumor necrosis factor (TNF) agents
Supply chain reliability becomes particularly crucial for specialty ingredients like GHK-Cu where alternative providers may require extensive revalidation
Verma et al
Also, low-concentration paclitaxel (2 nM) enhanced RSL3-induced ferroptosis by upregulating the expression of p53 variants Nanoformulations Nanoformulation using targeted nanoparticles such as dendrimers is an emerging strategy in cancer therapeutics
Prez-Madrigal MM, Shaw JE, Arno MC, Hoyland JA, Richardson SM, Dove AP